UROTHELIAL CARCINOMA BLADDER
Clinical trials for UROTHELIAL CARCINOMA BLADDER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA BLADDER trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
Disease control Not yet recruitingThis early-phase trial is testing a new biologic drug, UGN-501, for people whose non-muscle invasive bladder cancer has returned after previous treatment. The drug is given directly into the bladder through a catheter once a week for six weeks, with possible quarterly maintenance…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Electric shocks and calcium: a new hope for bladder cancer?
Disease control Not yet recruitingThis early-stage trial tests a procedure called calcium electroporation for bladder tumors. Doctors inject calcium into the tumor and then apply short electric pulses to destroy cancer cells. The study will include 20 patients who cannot have standard surgery or other treatments.…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: Juan Luis Vásquez • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New bladder cancer drug could spare patients from bladder removal
Disease control Not yet recruitingThis Phase 3 trial tests NDV-01, a sustained-release combination of two chemotherapy drugs (gemcitabine and docetaxel), given directly into the bladder. It aims to prevent cancer from coming back in people with non-muscle invasive bladder cancer, including those who have not resp…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC